Free tool
FAERS Monitor: Flarex
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019079 or its brand name (Flarex, Fluorometholone Acetate). Reports on generic versions are filed under their own applications.
Reports
267
Serious
102
38% of reports
Hospitalization
39
Death reported
8
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- eye pain64
- eye irritation30
- drug ineffective22
- vision blurred21
- headache19
- off label use19
- product dose omission issue19
- ocular hyperaemia18
- photophobia16
- fatigue15
- dizziness12
- diarrhoea11
- pain11
- wrong technique in product usage process11
- intraocular pressure increased10
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 3 |
| 2006 | 10 |
| 2008 | 3 |
| 2010 | 5 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 6 |
| 2015 | 4 |
| 2016 | 12 |
| 2017 | 9 |
| 2018 | 12 |
| 2019 | 9 |
| 2020 | 18 |
| 2021 | 23 |
| 2022 | 31 |
| 2023 | 58 |
| 2024 | 29 |
| 2025 | 19 |
| 2026 | 8 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,892 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| eye painSignal | 64 | 89.5 | 72.2 | 5,519 |
| photophobiaSignal | 16 | 67.1 | 41.7 | 976 |
| intraocular pressure increasedSignal | 10 | 61.7 | 33.6 | 538 |
| eye irritationSignal | 30 | 41.1 | 29.3 | 1,136 |
| ocular hyperaemiaSignal | 18 | 29.9 | 19.1 | 475 |
| vision blurredSignal | 21 | 12.0 | 8.0 | 203 |
| product dose omission issueSignal | 19 | 5.1 | 3.3 | 59 |
| wrong technique in product usage processSignal | 11 | 4.3 | 2.4 | 25 |
| headacheSignal | 19 | 2.4 | 1.5 | 14 |
| dizziness | 12 | 1.9 | 1.1 | 4 |
| off label use | 19 | 1.7 | 1.1 | 5 |
| fatigue | 15 | 1.5 | 0.9 | 2 |
| pain | 11 | 1.4 | 0.8 | 1 |
| diarrhoea | 11 | 1.3 | 0.8 | 1 |
| drug ineffective | 22 | 1.3 | 0.9 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.